Company
Headquarters: Verdellino, BG, Italy
Employees: 607
CEO: Mr. Marco Francesco Eigenmann
€228.2 Million
EUR as of Jan. 1, 2026
US$268.1 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Fine Foods & Pharmaceuticals N.T.M. S.p.A. engages in the contract development and manufacturing of oral solid forms for the pharmaceutical and nutraceutical industries. Its pharmaceutical products include powders and granules, tablets, film-coated tablets, and hard gelatine capsules; and nutraceutical products comprise soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, film-coated tablets, and hard gelatin capsules. The company also develops and manufactures medical devices for gastrointestinal treatment, oral and throat treatment, and weight management. Fine Foods & Pharmaceuticals N.T.M. S.p.A. was founded in 1984 and is based in Verdellino, Italy.
Fine Foods & Pharmaceuticals N.T.M. S.p.A. has the following listings and related stock indices.
Stock: MTA: FF wb_incandescent